circSYPL1 Promotes the Proliferation and Metastasis of Hepatocellular Carcinoma via the Upregulation of EZH2 Expression by Competing with hsa-miR-506-3p.

OBJECTIVE

Circular RNAs (circRNAs) and microRNAs are crucial for progressing of hepatocellular carcinoma (HCC). Nonetheless, the function or mechanisms of a newly discovered circRNA, circSYPL1, as well as miR-506-3p, in the progression of HCC are mostly unexplained. The purpose of this research was to determine the mechanisms by which circSYPL1 and miR-506-3p regulate the malignant features of HCC.

METHODS

The expression level of circSYPL1 was indeed detected using real-time PCR in HCC cell lines, primary as well as metastatic cancers. To assess the functionality of circSYPL1 upregulation and knockdown, we used proliferation and apoptosis, in addition to migration assays, as well as tumor xenograft and lung metastasis assays. The mechanisms of competing endogenous RNAs with circSYPL1/miR-506-3p/EZH2 were investigated using luciferase as well as RNA pull-down experiments. Lastly, cell proliferation and migration, in addition to tumor xenograft tests, were used to validate the biological significance of the circSYPL1/miR-506-3p/EZH2 signaling axis through overexpression or otherwise silencing.

RESULTS

circSYPL1 expression was significantly upregulated in HCC cell lines, in addition to primary and metastatic tumors of patients with HCC. Additionally, it may promote HCC initiation, development as well as progression. By knocking down circSYPL1 siRNA, we were able to drastically decrease the aggressiveness of HCC cells. circSYPL1 sponged miR-506-3p to boost EZH2 expression levels, as indicated by luciferase and RNA pull-down assays. Furthermore, circSYPL1 overexpression could upregulate EZH2 expression, while miR-506-3p mimics or EZH2 shRNAs could reverse the circSYPL1-induced malignancy of HCC cells.

CONCLUSION

On a mechanistic level, circSYPL1 can interact with miR-506-3p in a competitive manner to upregulate EZH2, hence increasing the aggressiveness of tumors.